Evidence map›Paper›PMID 40536716›Full record

Trial reportPsychopharmacology2025

Behavioral intervention with task repetition compared to pharmacological intervention with SSRI for enhancement of cognitive control in emotional and non-emotional settings.

Myrto Sklivanioti Greenfield, Yanlu Wang, Lina Martinsson, Tie-Qiang Li, Mussie Msghina

Abstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in Psychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Myrto Sklivanioti GreenfieldDepartment of Clinical Neuroscience (CNS), Karolinska Institute, Stockholm, Sweden. myrto.sklivanioti@ki.se.ORCID http://orcid.org/0000-0002-4742-9395
Yanlu WangDepartment of Nuclear Medicine Medical Physics, Karolinska University Hospital, Stockholm, Sweden.
Lina MartinssonDepartment of Clinical Neuroscience (CNS), Karolinska Institute, Stockholm, Sweden.
Tie-Qiang LiDepartment of Clinical Science, Intervention, and Technology, Karolinska Institute, Stockholm, Sweden.
Mussie MsghinaDepartment of Clinical Neuroscience (CNS), Karolinska Institute, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleCognitive control is crucial for optimal daily functioning and for emotional well-being. Cognitive control has been shown to be modified by experimental manipulations under widely differing experimental conditions, including cognitive training, and pharmacological intervention mainly probing catecholaminergic systems with little focus on the serotonergic system.

objectivesTo explore the role of serotonin on cognitive control in emotional and non-emotional settings.

methodsBehavioral, electrodermal and prefrontal activity measures were evaluated to compare the effects of single-session task repetition and single-dose serotonergic intervention with escitalopram on cognitive control in healthy participants, using cognitive and emotional Stroop tasks.

resultsFor cognitive Stroop, task repetition improved performance both 'on-line' within an ongoing task and 'off-line' after a four-hour delay, and escitalopram had no additional effects on this. In emotional Stroop, escitalopram enhanced the practice-related performance gain, starting from the second stimulus of each block. Compared to placebo, escitalopram also significantly reduced overall rate of premature responses. Regarding brain activation, escitalopram significantly reduced prefrontal activity during cognitive and even more so during emotional Stroop task. Lastly, electrodermal response showed significant habituation during cognitive but not emotional Stroop, in an effect that was not significantly modified by escitalopram.

conclusionsCognitive control in emotional and non-emotional settings may respond differently to behavioral and pharmacological manipulations. Escitalopram may selectively improve cognitive control in an emotional setting compared to cognitive control in non-emotional settings.

Indexed as

CognitionEmotionsEscitalopramSelective Serotonin Reuptake InhibitorsAdultCitalopramDouble-Blind MethodFemaleGalvanic Skin ResponseHumansMalePrefrontal CortexStroop TestYoung AdultCitalopramEscitalopramSelective Serotonin Reuptake InhibitorsCognitive controlEDAEmotion regulationEscitalopramFNIRSPFCTraining

Identifiers

PMID40536716
PMCPMC12675703

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.